BioAge Labs Plans Upsized US IPO, Eyes Valuation of Nearly $640 Million
BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United […]
BioAge Labs Plans Upsized US IPO, Eyes Valuation of Nearly $640 Million Read More »
